Advance Auto -24%: EPS Beat, Guide Raised, DIY Cracked
Advance Auto Parts crashed 24.55% on August 20 even after beating on EPS and raising 2026 guidance. Here’s what actually broke — and what it means for the consumer trade.
Bruno M.
How an IPO Actually Works: S-1, Roadshow, Greenshoe, Lock-Up
IPO 101 with real numbers: what an S-1 filing is, how bookbuilding sets the price, why greenshoes and lock-ups exist, and what first-day pops mean.
Treasury Doubles Long-End Bond Buybacks to $4B Per Op
Treasury will at least double liquidity-support buybacks in the 10-30Y sector to $4B per operation starting Sept 9. Bessent signals more could come.
Walmart Beats and Raises but WMT Falls 9.7% to 52-Week Low
Walmart topped estimates and raised FY27 guidance, yet WMT fell 9.74% to $103.17. Soft US comps, a tariff-refund-funded raise, flat Q3 EPS, and higher capex explain why.
Quad Witching Explained: What Happens on Expiration Friday
Quad witching is really triple witching now: three contract types expire on the third Friday of Mar, Jun, Sep, Dec. Here’s the real mechanics.
Anthropic Lines Up $10B+ Bank Credit Ahead of IPO
Morgan Stanley, Goldman and JPMorgan each writing $1.25B into Anthropic’s $10B+ revolver, jockeying for lead roles on a $2T IPO targeted for October.
Target Q2: EPS $4.11, Comps +3.8%, Turnaround Traction
Target Q2 2026 earnings: EPS $4.11 (up 20% ex-tariff refund), comps +3.8%, digital +8.7%, guidance lifted. Stock +4.3% as turnaround gains traction.
Convertible Bonds Explained: Coupon, Premium, Dilution
What is a convertible bond? Coupon savings, conversion premium, dilution risk, and how hedge funds run convertible arbitrage — with real examples.
US Debt Crosses $40 Trillion: Every $1T in 5 Months
US public debt topped $40 trillion on Aug 18, 2026, per Treasury. The last two trillion arrived in about five months each.
Moderna +177%, Merck +13% on Melanoma Vaccine Phase 3 Win
Moderna soared 177% and Merck jumped 13% on Aug 19 after intismeran plus Keytruda hit its primary endpoint in the Phase 3 INTerpath-001 melanoma trial.